← Back to Search

Nudge for Pre-eclampsia (REMIND Trial)

N/A
Waitlist Available
Led By Jourdan E Triebwasser, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months postpartum
Awards & highlights
No Placebo-Only Group

Summary

This trial will examine whether sending electronic reminders to obstetric care providers (nudge) can improve postpartum counseling and follow-up with preventative care providers for women with HDP.

Eligible Conditions
  • Pre-Eclampsia, Severe
  • Preeclampsia
  • Prophylaxis of Preeclampsia
  • Hypertension
  • Pre-eclampsia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months postpartum
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months postpartum for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Patients With Documented Counseling on Transitions of Care
Secondary study objectives
Nudge Message Opened Within 1 Week of Receipt
Number of Participants With Postpartum Visit Notes That Used Example Text
Number of Patients With Documented Counseling on Cardiovascular Disease (CVD) Risk at the Postpartum Visit
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: NudgeExperimental Treatment1 Intervention
Obstetric care providers will receive electronic prompts (nudge) for participants in this arm
Group II: Usual careActive Control1 Intervention
Usual postpartum follow-up with visit at 4-12 weeks postpartum
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nudge
2022
N/A
~56380

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,082 Previous Clinical Trials
42,727,287 Total Patients Enrolled
Jourdan E Triebwasser, MDPrincipal InvestigatorUniversity of Pennsylvania
~47 spots leftby Nov 2025